Global Endoscopy Devices Market Size, Forecast, and Trend Highlights Over 2025-2037
Endoscopy Devices Market size was over USD 60.91 billion in 2024 and is set to reach USD 98.91 billion by the end of 2037, witnessing around 3.8% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of endoscopy devices is estimated at USD 62.53 billion.
The market is impelled by the increasing worldwide prevalence of chronic ailments such as cancer, gastrointestinal disorders, and cardiovascular diseases (CVD). According to the GLOBOCON statistics, the number of new and death cases of cancer around the globe is expected to reach 4.6 million and 3.5 million by 2050. Similarly, an NLM projection calculated the global count of CVD deaths to reach 20.5 million by 2025 and 35.6 million by 2050. It also predicted 90%, 73.4%, and 54.7% increments in crude prevalence, mortality, and disability-adjusted life-years (DALYs) throughout the same timeframe. These medical issues require high-end diagnostic and therapeutic procedures to enable early detection and intervention to prevent them from worsening.
The payers’ pricing of commodities from the market varies as per the type of procedure, technology used, and device. For instance, in November 2022, NLM published a comparative cost-analysis of oral, transnasal, and magnet-assisted capsule endoscopy, examining the upper gastrointestinal tract in dyspepsia. Per procedure expense for transnasal endoscopy (TNE) had the lowest value of USD 142.8, in comparison to the oral and magnet-assisted one (USD 208.8 and USD 461.7). On the other hand, the annual purchase and maintenance costs of oral and TNE instruments were USD 89982and USD 92805.2, respectively, higher than USD 17490.5 for the magnet-assisted system. Thus, the need for standardized pricing is highly required to make this sector more publicly accessible.
Endoscopy Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Tech-based operations in surgical interventions: Technological advancements, such as the integration of robotics and AI, are believed to fuel growth in the endoscopy devices market. For instance, in March 2024, Fujifilm gained 510(k) clearance from the FDA for its novel AI detection system, CAD EYE, for endoscopic imaging. This compatible tool enables endoscopists the ability to offer real-time detection and removal of colonic mucosal lesions such as polyps and adenomas, irrespective of their size, shape, and color. High sensitivity and accuracy, delivered by such next-generation tools, in all simple and complex procedures are inspiring more healthcare settings to invest in this sector.
- Increasing popularity of minimally invasive procedures: The rapid shift of consumer preference towards procedures with fewer incisions and faster recovery is fueling growth in the market. This approach of less-invasive treatments allows doctors to see within the body without creating any incisions, as the associated instruments are directly put into organs through anus or mouth openings. Moreover, endoscopic surgeries provide cost-saving benefits such as fewer hospital stays and reduced risk of infection, boosting demand in this sector. This fact can also be testified by the expanding global endoscopes industry, which is predicted to attain USD 26.3 billion by 2025 and USD 49.6 billion by 2037.
Challenges
- Risk of acquiring healthcare-associated infection (HAI): The most common instruments, used in clinical practice, from the market are often linked to bacterial infection outbreaks. This can be acquired outside or internally through contaminated equipment or from endoscopic staff members to patients. On the other hand, the development of sophisticated non-autoclavable fiberoptic endoscopes has made sterilizing the instrument technically impractical as appropriate cleaning of flexible scopes is still a challenge. It may further raise the possibility of transmitting unwanted bacterial infections, creating concerns about the product’s safety profile. However, the introduction of safer alternatives has the potential to mitigate this issue.
Endoscopy Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
3.8% |
|
Base Year Market Size (2024) |
USD 60.91 billion |
|
Forecast Year Market Size (2037) |
USD 98.91 billion |
|
Regional Scope |
|
Endoscopy Devices Segmentation
Device Type (Endoscopes, Endoscopic Operative Device, Visualization Equipment)
The endoscopes segment is estimated to account for a 37% share of the global endoscopy devices market throughout the assessed timeframe. There are multiple drivers behind this segment’s predominant captivity, such as rising investments in medical infrastructure, ongoing technological upgradation, and growing adoption of ambulatory surgical centers (ASCs). Additionally, new advancements are widening endoscopic applications, such as bariatric surgery for weight reduction, broadening the consumer base for this segment. The increasing use of disposable and single-use endoscopes due to financial benefits is also contributing to the segment’s greater revenue generation. For instance, a 2021 Journal of Hand Surgery concluded a USD 102 cost-saving in disposable endoscopic carpal tunnel release procedure.
Application (Gastroenterology, Pulmonology, Orthopedic Surgery, Cardiology, ENT Surgery, Gynecology, Neurology)
The endoscopy devices market from the gastroenterology segment is set to garner a notable share by the end of 2037. The high prevalence of gastrointestinal disorders, advancements in endoscopic technologies, and growing awareness of the advantages of early detection & treatment are expected to maintain this segment’s dominance. As per a 2020 NLM study, the new and death cases of gastrointestinal cancer (GI) around the world are poised to increase by 58% and 73% by 2040, accounting for 7.5 million and 5.6 million respectively. Currently, the most prevalent locations of this malignancy are the colorectum, stomach, Liver, Esophagus, and Pancreas. In addition, the global population of residents with peptic ulcers surpassed 4 million in 2022 (NLM). This demography is a clear indication of stable capital influx in this segment.
Our in-depth analysis of the global endoscopy devices market includes the following segments:
|
Device Type |
|
|
End user |
|
|
Application |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportEndoscopy Devices Industry - Regional Synopsis
North American Market Forecast
The endoscopy devices market in North America is predicted to account for the largest share of 43% over the discussed timeframe. The improved availability and accessibility of associated procedures impels the region’s leadership. This is expected to create a huge demand for these devices. In addition, the patient population is continuously magnifying due to the presence of high-risk factors such as obesity, alcohol consumption, and sedentary lifestyles. For instance, in 2022, the estimated number of new and death cases of gastrointestinal cancer (GI) in the U.S. was 343,040 and 171,920, accounting for 18% and 28% of the total cancer incidence and mortality. These figures are further expected to rise by 9.8% & 11.5% and 27.9% & 21.9% for men & women in the country, respectively (American Journal of Gastroenterology).
According to a 2020 NLM study, the annual count of gastrointestinal endoscopies performed in the U.S. surpassed 75million and over 19million of them were colonoscopies. Other projections from the Gastrojournal concluded the nationwide annual expenditure on GI cancer management to reach USD 21billion by 2030. These figures indicate the heightening surge in the U.S. market, attracting global leaders to participate. On this note, in October 2023, Olympus Corporation initiated the commercialization of its EVIS X1 Endoscopy System in this country, as per the announcement in the annual meeting of the American College of Gastroenterology (ACG), held in Vancouver, Canada.
APAC Market Statistics
The Asia Pacific endoscopy devices market is anticipated to be the second largest shareholder by exhibiting a notable CAGR during the forecast timeline. Recent developments and expansion in the healthcare industries from developing countries, such as Japan, China, and India, are driving the region’s propagation. Particularly, continuous funding from governments, foreign investors, and domestic pioneers to establish a strong and efficient network of medical infrastructure is contributing to its progress. For instance, by the end of 2023, foreign direct investments (FDI) in hospitals in India totaled USD 1.5 billion, accounting for 50% of the total healthcare FDI of the nation. This secure capital influx is further inspiring global pioneers to cultivate their channels of marketing in this landscape.
Japan is emerging as the hub of innovation for the market due to being home to several internationally recognized companies such as Fujifilm, Olympus Corporation, and PENTAX Medical. For instance, in January 2023, PENTAX Medical attained the CE mark for its new premium video processor and video endoscope series, INSPIRA and the i20c, supporting their commercial launch. The country’s enlarging medical device industry is also solid evidence of its technological leadership in this field. In this regard, the International Trade Administration reported that the domestic production of medical devices in this country was valued at USD 19.5 billion in 2022. It also calculated the size of this industry in Japan to surpass USD 40.1 billion in the same year.
Companies Dominating the Endoscopy Devices Landscape
- Ethicon Endo-surgery, LLC.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Stryker Corporation
- Boston Scientific Corporation
- Karl Storz GmbH & Co. KG
- Smith & Nephew Inc.
- Richard Wolf GmbH
- Medtronic Plc (Covidien)
- PENTAX Medical
- Machida Endoscope Co., Ltd.
- FUJIFILM Healthcare
- Olympus Corporation
The market is continuously evolving with the integration of technological advances in the existing pipelines. Key players in this sector are participating in the trend of automation by introducing AI-powered next-generation systems. For instance, in October 2024, Olympus Corporation, in collaboration with Odin Medical, earned CE clearance for its three cloud-AI-based medical devices, CADDIE, CADU, and SMARTIBD. With this regulatory support from the European Union, the company further aimed to cultivate a complete AI-powered endoscopy ecosystem by 2025 to streamline the workflow for medical professionals. Such innovations are attracting both MedTech pioneers and consumers to invest in this sector. This cohort of innovators includes:
In the News
- In April 2025, FUJIFILM announced the commercial launch of its new advanced endoscopy system, ELUXEO 8000, in Europe. This innovation is designed to deliver additional enhanced therapeutic capabilities, workflow management, and improved image quality.
- In September 2024, Olympus made its most advanced endoscopy system, EVIS X1, commercially available in Brazil. This device is equipped with advanced imaging technologies, such as Texture and Color Enhancement, Red Dichromatic, Brightness Adjustment with Maintenance of Contrast, and Narrow Band.
Author Credits: Radhika Pawar
- Report ID: 5420
- Published Date: May 05, 2025
- Report Format: PDF, PPT
